Inflammation: What's There and What's New?

被引:5
|
作者
Calhelha, Ricardo C. [1 ,2 ]
Haddad, Hala [1 ,2 ]
Ribeiro, Lucia [1 ,2 ]
Heleno, Sandrina A. [1 ,2 ]
Carocho, Marcio [1 ,2 ]
Barros, Lillian [1 ,2 ]
机构
[1] Inst Politecn Braganca, Ctr Invest Montanha CIMO, Campus Santa Apolonia, P-5300253 Braganca, Portugal
[2] Inst Politecn Braganca, Lab Sustentabilidade & Tecnol Regioes Montanha Sus, Campus Santa Apolonia, P-5300253 Braganca, Portugal
来源
APPLIED SCIENCES-BASEL | 2023年 / 13卷 / 04期
关键词
inflammation; synthetic anti-inflammatory agents; natural anti-inflammatory agents; mechanisms of action; in vitro and in vivo anti-inflammatory assays; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; NF-KAPPA-B; TISSUE FACTOR; ZINGIBER-OFFICINALE; IMMUNE-RESPONSE; TGF-BETA; COMPLEMENT; MECHANISMS; LOCALIZATION; APOPTOSIS;
D O I
10.3390/app13042312
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Since the dawn of man, inflammation has been known to humanity, as it is marked by pain. Inflammation processes are related to serious chronic diseases with irreversible damage to the organism, being crucial for the development of anti-inflammatory agents. Among the existing anti-inflammatory drugs, non-steroidal and glucocorticoids are commonly used; however, these compounds have been described as responsible for the increased risk of upper gastrointestinal complications and many other side effects. Therefore, it is not shocking that ethnobotany leads most modern studies on the discovery of anti-inflammatory agents obtained from natural matrices. Extracts from plants and isolated substances have demonstrated anti-inflammatory effects in a set of in vitro and in vivo anti-inflammatory models. This review describes inflammation processes with an emphasis on the most common related diseases, while also describing the most promising natural anti-inflammatory agents, by reporting on their obtention processes, mechanisms of action, and applications.
引用
收藏
页数:26
相关论文
共 50 条
  • [21] Prague 2007: What's new, what's on, what's next.
    Ross, Janet
    LIBRARY JOURNAL, 2006, 131 (20) : 146 - 146
  • [22] PET Radiopharmaceuticals: What's New, What's Reimbursed, and What's Next?
    Clarke, Bonnie N.
    JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY, 2018, 46 (01) : 12 - 16
  • [23] Genetics of dystonia: What's known? What's new? What's next?
    Lohmann, Katja
    Klein, Christine
    MOVEMENT DISORDERS, 2013, 28 (07) : 899 - 905
  • [24] The Subprime Turmoil: What's Old, What's New, and What's Next
    Calomiris, Charles W.
    JOURNAL OF STRUCTURED FINANCE, 2009, 15 (01): : 6 - 52
  • [25] The technological family: What's new and what's not
    Garrison, M
    FAMILY LAW QUARTERLY, 1999, 33 (03) : 691 - 704
  • [26] Ethical dilemmas - What's new, what's not
    Silverman, S
    ETHICS AND ANTHROPOLOGY: FACING FUTURE ISSUES IN HUMAN BIOLOGY, GLOBALISM, AND CULTURAL PROPERTY, 2000, 925 : 211 - 215
  • [27] JoPAN: What's Old and What's New!
    Odom-Forren, Jan
    JOURNAL OF PERIANESTHESIA NURSING, 2015, 30 (04) : 263 - 264
  • [28] What's Current and What's New in Mesothelioma?
    Leal, J. L.
    Hoang, W.
    Xue, J.
    Dunne, B.
    John, T.
    Harden, S.
    CLINICAL ONCOLOGY, 2022, 34 (11) : 771 - 780
  • [29] Gadonanotubes: What's new and what's next?
    Wilson, Lon J.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 247
  • [30] Immunosuppression: What's Standard and What's New?
    Witt, Chad A.
    Hachem, Ramsey R.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 34 (03) : 405 - 413